MARCO and fibrosis: Moreover, targeted reduction of cutaneous and pulmonary infiltration of MARCO+ inflammatory monocytes and macrophages using an innovative PLG nanoparticle strategy effectively prevented and, more importantly, reversed skin and lung pathology in a BLM-induced mouse model of fibrosis.